Docj, It is a lot of money….for Cytodyn to pa
Post# of 148161
It is a lot of money….for Cytodyn to pay for allegedly wholly insufficient work.
Cytodyn’s leverage is money. Amarex’s leverage is data.
It appears that Cytodyn has prevailed in round one.
Perhaps there will be an analysis and determination of what portion of the work is value and for which payment should be made.